Frederick Driscoll - NantKwest Independent Director

Director

Mr. Frederick W. Driscoll is Independent Director of the Company. Mr. Driscoll served as Chief Financial Officer at Flexion Therapeutics, Inc., a publicly traded specialty pharmaceutical company, from 2013 until his retirement in March 2017. Prior to Flexion, he was Chief Financial Officer at Novavax, Inc., a publicly traded biopharmaceutical company, from 2009 to 2013. From 2008 to 2009, Mr. Driscoll served as Chief Executive Officer of Genelabs Technologies, Inc., a publicly traded biopharmaceutical and diagnostics company later acquired by GlaxoSmithKline. He previously served as Genelabs Chief Financial Officer from 2007 to 2008. From 2000 to 2006, Mr. Driscoll served as Chief Executive Officer at OXiGENE, Inc., a biopharmaceutical company. Mr. Driscoll has also served as Chairman of the Board and Audit Committee Chair at OXiGENE and as a member of the Audit Committee for Cynapsus Therapeutics, Inc., which was sold to Sunovion Pharmaceuticals in 2016 since 2017.
Age 67
Tenure 7 years
Phone858 633-0300
Webwww.nantkwest.com
Driscoll currently serves on the boards of MEI Pharma, Cue Biotherapeutics and Cellectar Bioscience. He earned a Bachelor’s degree in accounting and finance from Bentley University. We believe that Mr. Driscoll is qualified to serve as a member of our board of directors because of his extensive experience and knowledge in the healthcare industry and his significant financial and accounting background.

NantKwest Management Efficiency

The company has Return on Asset (ROA) of (38.83) % which means that for every 100 dollars spent on asset, it generated a loss of $38.83. This is way below average. Likewise, it shows a return on total equity (ROE) of (77.61) %, which implies that it produced no returns to current stockholders. NantKwest's management efficiency ratios could be used to measure how well NantKwest manages its routine affairs as well as how well it operates its assets and liabilities.
The company reports 15.31 M of total liabilities with total debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from financial leverage. NantKwest has a current ratio of 3.0, indicating that it is in good position to pay out its debt commitments in time. Debt can assist NantKwest until it has trouble settling it off, either with new capital or with free cash flow. So, NantKwest's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NantKwest sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NantKwest to invest in growth at high rates of return. When we think about NantKwest's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Shihua LuZijin Mining Group
66
Graciela MonteagudoAcco Brands
54
Ganpat ManiUranium Energy Corp
71
Thomas KroegerAcco Brands
72
Robert JenkinsAcco Brands
72
Ivan ObolenskyUranium Energy Corp
90
George BaylyAcco Brands
73
Laichang ZouZijin Mining Group
55
Joon JyoungFranklin Wireless Corp
75
Hoi SitZijin Mining Group
56
Jianguo LiZijin Mining Group
41
James BuzzardAcco Brands
65
Guang ZhuZijin Mining Group
60
Guanzhou QiuZijin Mining Group
65
Tok KongUranium Energy Corp
72
Kathleen DvorakAcco Brands
64
Shida DingZijin Mining Group
67
Vincent VolpeUranium Energy Corp
76
Pradeep JotwaniAcco Brands
66
Ronald LombardiAcco Brands
57
Hans NorkusAcco Brands
73
NantKwest, Inc., a clinical-stage immunotherapy company, develops immunotherapeutic treatments for cancer and viral infectious diseases in the United States. NantKwest, Inc. was founded in 2002 and is headquartered in San Diego, California. Nantkwest Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. NantKwest (NK) is traded on NASDAQ Exchange in USA and employs 160 people.

Management Performance

NantKwest Leadership Team

Elected by the shareholders, the NantKwest's board of directors comprises two types of representatives: NantKwest inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NantKwest. The board's role is to monitor NantKwest's management team and ensure that shareholders' interests are well served. NantKwest's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NantKwest's outside directors are responsible for providing unbiased perspectives on the board's policies.
Cheryl Cohen, Director
Richard Kusserow, Independent Director
Angela Wilson, CFO
Sonja Nelson, Chief Accounting Officer
Barry Simon, President CEO, Board Member
Michael Blaszyk, Independent Director
Frederick Driscoll, Independent Director
John Thomas, Independent Director
Robert Rosen, Director
Richard Tajak, Interim CFO
Patrick SoonShiong, Chairman of the Board, CEO
Henry Ji, Director
John Potts, Independent Director
Steven Gorlin, Vice Chairman of the Board

NantKwest Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NantKwest a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in NantKwest Stock

If you are still planning to invest in NantKwest check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NantKwest's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
CEOs Directory
Screen CEOs from public companies around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Transaction History
View history of all your transactions and understand their impact on performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins